| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |